Role of Macrophage Subsets in CD8+ T Cell Dysfunction in Chronic HCV Infection

Chronic HCV infection causes generalized CD8+T cell impairment, not limited to HCV-specific CD8+ T cells. Infiltrating monocyte-derived macrophages contribute to a micro- environment that could impact CD8+T cells trafficking through the liver. Macrophages can differentiate into pro-inflammatory (M1)...

Full description

Bibliographic Details
Main Author: Ahmed, Faria
Other Authors: Kumar, Ashok
Format: Others
Language:en
Published: Université d'Ottawa / University of Ottawa 2018
Subjects:
HCV
Online Access:http://hdl.handle.net/10393/38227
http://dx.doi.org/10.20381/ruor-22481
Description
Summary:Chronic HCV infection causes generalized CD8+T cell impairment, not limited to HCV-specific CD8+ T cells. Infiltrating monocyte-derived macrophages contribute to a micro- environment that could impact CD8+T cells trafficking through the liver. Macrophages can differentiate into pro-inflammatory (M1) and anti-inflammatory (M2a, M2b, and M2c) subsets. Whether macrophage subset generation in chronic HCV infection is altered and if that has a subsequent impact on CD8+T cell functions was not known. I have shown phenotypic alterations in both M1 and M2 macrophages in chronic HCV infection. In particular, M1 from advanced fibrosis patients show increased CD86 expression, reduced spontaneous TNF-α and increased spontaneous IL-10 production. In uninfected controls, co-culturing CD8+T cells with M1 macrophages significantly increased the percentage of CD107a+ and IFN-γ+ CD8+T cells in a contact-dependent manner. Similar autologous co-cultures between M1 and CD8+T cells from patients with chronic HCV infection showed that M1 significantly reduced the percentage of IFN-γ+ CD8+T cells, even though patients displayed elevated IFN-γ+CD8+ T cells at baseline prior to culture. Overall, I demonstrated the altered phenotype of macrophages generated from patients with chronic HCV infection. I also showed the ability of M1 macrophages to induce IFN-γ+CD8+T cells in normal donors and their opposite impact when the cells are derived from chronic HCV infected patients.